Form 8-K - Current report:
SEC Accession No. 0000950170-25-078375
Filing Date
2025-05-28
Accepted
2025-05-28 16:30:14
Documents
10
Period of Report
2025-05-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K okur-20250527.htm   iXBRL 8-K 66830
  Complete submission text file 0000950170-25-078375.txt   173476

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT okur-20250527.xsd EX-101.SCH 24879
12 EXTRACTED XBRL INSTANCE DOCUMENT okur-20250527_htm.xml XML 4720
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 25995794
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)